NTLA icon

Intellia Therapeutics
NTLA

Overview Fund Activity

164 hedge funds and large institutions have $1.13B invested in Intellia Therapeutics in 2020 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 58 increasing their positions, 32 reducing their positions, and 19 closing their positions.

Holders
164
Holders Change
+24
Holders Change %
+17.14%
% of All Funds
3.37%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
43
Increased
58
Reduced
32
Closed
19
Calls
$5.7M
Puts
$2.52M
Net Calls
+$3.18M
Net Calls Change
+$3.73M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$28.4M
2
BlackRock
2
BlackRock
New York
$106M
3
AIM
3
ARK Investment Management
Florida
$240M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$18.3M
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$33.8M

Top Sellers

1
Sumitomo Mitsui Trust Group
1
Sumitomo Mitsui Trust Group
Japan
$130M
2
NAMA
2
Nikko Asset Management Americas
New York
$124M
3
Citadel Advisors
3
Citadel Advisors
Florida
$15.6M
4
O
4
OrbiMed
New York
$2.88M
5
IC
5
Ikarian Capital
Texas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Walleye Capital
176
Walleye Capital
New York
– -$18K -1,485 Closed
SPIA
177
Steward Partners Investment Advisory
New York
– -$4K -400 Closed
GI
178
Gradient Investments
Minnesota
– -$2K -162 Closed
NFG
179
Next Financial Group
Texas
– -$1K -100 Closed
AA
180
Advisory Alpha
Michigan
– -$1.42K -100 Closed
4 5 6 7
8